TIRZEPATIDE
Dual GIP/GLP-1 receptor agonist research compound studied for incretin receptor signaling pathways and related metabolic research models in laboratory settings.
Shipped in an insulated package with ice pack to maintain product integrity during transit.
More Info:
Sequence: Tyr-{Aib}-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{Aib}-Leu-Asp-Lys-Ile-Ala-Gln-{Lys(AEEA-AEEA-γ-Glu-C20 diacid)}-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH₂ (39 amino acids with Aib substitutions and C20 fatty diacid conjugation)
• Molecular formula: C₂₂₅H₃₄₈N₄₈O₆₈
• Molecular weight: ≈ 4813.5 Da
• Framing: Synthetic dual GIP/GLP-1 receptor agonist peptide. Features non-natural amino acid substitutions (Aib) and a fatty-acid side chain for extended half-life studies. Used in research examining incretin receptor signaling and metabolic pathway models. Typically supplied as the acetate or TFA salt in lyophilized form.
TIRZEPATIDE
Dual GIP/GLP-1 receptor agonist research compound studied for incretin receptor signaling pathways and related metabolic research models in laboratory settings.
Shipped in an insulated package with ice pack to maintain product integrity during transit.
More Info:
Sequence: Tyr-{Aib}-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{Aib}-Leu-Asp-Lys-Ile-Ala-Gln-{Lys(AEEA-AEEA-γ-Glu-C20 diacid)}-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH₂ (39 amino acids with Aib substitutions and C20 fatty diacid conjugation)
• Molecular formula: C₂₂₅H₃₄₈N₄₈O₆₈
• Molecular weight: ≈ 4813.5 Da
• Framing: Synthetic dual GIP/GLP-1 receptor agonist peptide. Features non-natural amino acid substitutions (Aib) and a fatty-acid side chain for extended half-life studies. Used in research examining incretin receptor signaling and metabolic pathway models. Typically supplied as the acetate or TFA salt in lyophilized form.
